![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0096.png)
96
[110] G. Tadini, D. Milani, F. Menni, L. Pezzani, C. Sabatini, and S. Esposito, “Is it time to change the
neurofibromatosis 1 diagnostic criteria?,”
Eur. J. Intern. Med.
, vol. 25, no. 6, pp. 506–510, Jul. 2014.
[111] M. Khodaee, “Painless cutaneous nodules,”
J. Fam. Pract.
, vol. 61, no. 8, pp. 489–491, Aug. 2012.
[112] L. K. Kriechbaumer, M. Susani, S. G. Kircher, and W. Happak, “Vaporization of cutaneous
neurofibromas with an erbium: yttrium-aluminum-garnet laser: a comparative histologic evaluation,”
Plast. Reconstr. Surg.
, vol. 129, no. 3, p. 602e–604e, Mar. 2012.
[113] Nederlandse Vereniging voor Dermatologie en Venereologie, “Richtlijn Laserbehandeling en
flitslamptherapie.” 2004.
[114] V. S. Warbey, R. E. Ferner, J. T. Dunn, E. Calonje, and M. J. O’Doherty, “[18F]FDG PET/CT in the
diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1,”
Eur. J. Nucl. Med.
Mol. Imaging
, vol. 36, no. 5, pp. 751–757, May 2009.
[115] C. E. Prada, F. A. Rangwala, L. J. Martin, A. M. Lovell, H. M. Saal, E. K. Schorry, and R. J. Hopkin,
“Pediatric Plexiform Neurofibromas: Impact on Morbidity and Mortality in Neurofibromatosis Type 1,”
J.
Pediatr.
, vol. 160, no. 3, pp. 461–467, Mar. 2012.
[116] NVK and CBO, “Pijnmeting en behandeling van pijn bij kinderen.” 2007.
[117] D. A. Stevenson, D. Little, L. Armstrong, A. H. Crawford, D. Eastwood, J. M. Friedman, T. Greggi, G.
Gutierrez, K. Hunter-Schaedle, D. L. Kendler, M. Kolanczyk, F. Monsell, M. Oetgen, B. S. Richards, A.
Schindeler, E. K. Schorry, D. Wilkes, D. H. Viskochil, F.-C. Yang, and F. Elefteriou, “Approaches to treating
NF1 tibial pseudarthrosis: consensus from the Children’s Tumor Foundation NF1 Bone Abnormalities
Consortium,”
J. Pediatr. Orthop.
, vol. 33, no. 3, pp. 269–275, May 2013.
[118] N. G. Gandhi, “Treatment of neuro-ophthalmic and orbitofacial manifestations of neurofibromatosis
type 1,”
Curr. Opin. Ophthalmol.
, Jul. 2013.
[119] G. Nicolin, P. Parkin, D. Mabbott, D. Hargrave, U. Bartels, U. Tabori, J. Rutka, J. R. Buncic, and E.
Bouffet, “Natural history and outcome of optic pathway gliomas in children,”
Pediatr. Blood Cancer
, vol.
53, no. 7, pp. 1231–1237, Dec. 2009.
[120] L. Rehbock and R. F. Neuteboom, “Richtlijn: hoofdpijn bij kinderen.” Erasmus Medisch Centrum
Rotterdam, Jun-2013.
[121] Commissie Kwaliteit van de, Nederlandse Vereniging voor Neurologie, and Werkgroep Richtlijnen
Hoofdpijn, “Richtlijnen diagnostiek en behandeling chronisch recidiverende hoofdpijn zonder
neurologische afwijkingen.” 2007.
[122] I. Pascual-Castroviejo, S. I. Pascual-Pascual, R. Velázquez-Fragua, J. Viaño, and F. Carceller-Benito,
“[Aqueductal stenosis in the neurofibromatosis type 1. Presentation of 19 infantile patients],”
Rev.
Neurol.
, vol. 45, no. 1, pp. 18–21, Jul. 2007.
[123] A. P. Ostendorf, D. H. Gutmann, and J. L. Z. Weisenberg, “Epilepsy in individuals with
neurofibromatosis type 1,”
Epilepsia
, vol. 54, no. 10, pp. 1810–1814, Oct. 2013.
[124] M. Runke and V. Salanova, “Epilepsy due to a cortical malformation in a Neurofibromatosis type 1
patient,”
Seizure J. Br. Epilepsy Assoc.
, vol. 22, no. 6, pp. 476–479, Jul. 2013.
[125] C. Barba, T. Jacques, P. Kahane, T. Polster, J. Isnard, F. S. S. Leijten, C. Ozkara, L. Tassi, F. Giordano, M.
Castagna, A. John, B. Oz, C. Salon, N. Streichenberger, J. H. Cross, and R. Guerrini, “Epilepsy surgery in
Neurofibromatosis Type 1,”
Epilepsy Res.
, vol. 105, no. 3, pp. 384–395, Aug. 2013.
[126] Nederlandse Vereniging voor Neurologie en de Nederlandse Liga tegen Epilepsie, “Epilepsie.
Richtlijnen voor diagnostiek en behandeling.” 2006.
[127] T. L. Rosser, G. Vezina, and R. J. Packer, “Cerebrovascular abnormalities in a population of children
with neurofibromatosis type 1,”
Neurology
, vol. 64, no. 3, pp. 553–555, Feb. 2005.
[128] Kennisnetwerk CVA and Platvorm Vitale Vaten, “Zorgstandaard CVA/TIA.” Nov-2012.
[129] L. C. Krab, F. K. Aarsen, A. de Goede-Bolder, C. E. Catsman-Berrevoets, W. F. Arts, H. A. Moll, and Y.
Elgersma, “Impact of neurofibromatosis type 1 on school performance,”
J Child Neurol
, vol. 23, no. 9, pp.
1002–10, 2008.